| Description | 4,6-Benzilidine-D-Glucose is a clinical antitumor compound showing antitumor activity in rats with chemically induced hepatocellular carcinoma. |
| molecular weight | 268.26 |
| Molecular formula | C13H16O6 |
| CAS | 30688-66-5 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
| Solubility | Ethanol: 22.5 mg/mL (83.9 mM) DMF: 22.5 mg/mL (83.9 mM) DMSO: 60 mg/mL (223.66 mM), Sonication is recommended. |
| References | 1. Pettersen EO, et al. Effect on protein synthesis and cell survival of the benzaldehyde derivatives sodium benzylidene ascorbate (SBA) and the deuterated compound zilascorb(2H). Anticancer Res. 1991;11(3):1077-1081. 2. Wimmer S, et al. Synthesis, biological evaluation, and molecular docking studies of aldotetronic acid-based LpxC inhibitors. Bioorg Chem. 2023;131:106331. |